Comparison between sodium–glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta‐analysis

AIMS/INTRODUCTION: We aimed to evaluate the efficacy and safety of pioglitazone (PIO) and sodium–glucose cotransporter 2 inhibitors (SGLT2i) as additions to insulin therapy for the management of type 2 diabetes mellitus. MATERIALS AND METHODS: We searched PubMed, EMBASE, the Cochrane Central Registe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Yun Kyung, Kim, Ye‐Jee, Kang, Yu Mi, Lee, Seung Eun, Park, Joong‐Yeol, Lee, Woo Je, Jung, Chang Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031497/
https://www.ncbi.nlm.nih.gov/pubmed/29215196
http://dx.doi.org/10.1111/jdi.12787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031497/
https://www.ncbi.nlm.nih.gov/pubmed/29215196
http://dx.doi.org/10.1111/jdi.12787

Ejemplares similares